Innate Pharma
1D
1W
1M
3M
YTD
1Y
5Y
ALL
Why Robinhood?
You can watch Innate Pharma and buy or sell other stocks, ETFs, and their options commission-free!About IPHA
Innate Pharma SA is a global, clinical-stage biotechnology company, which engages in developing immunotherapies for cancer patients. Its product pipeline includes Lacutamab, Monalizumab, Avdoralimab, and IPH62.
CEOJonathan Dickinson
CEOJonathan Dickinson
Employees163
Employees163
HeadquartersMarseille, Provence-Alpes-Cote-dAzur
HeadquartersMarseille, Provence-Alpes-Cote-dAzur
Founded1999
Founded1999
Employees163
Employees163
IPHA Key Statistics
Market cap136.16M
Market cap136.16M
Price-Earnings ratio-2.28
Price-Earnings ratio-2.28
Dividend yield—
Dividend yield—
Average volume21.98K
Average volume21.98K
High today$1.46
High today$1.46
Low today$1.42
Low today$1.42
Open price$1.45
Open price$1.45
Volume52.53K
Volume52.53K
52 Week high$2.63
52 Week high$2.63
52 Week low$1.17
52 Week low$1.17
Analyst ratings
83%
of 6 ratingsBuy
83.3%
Hold
16.7%
Sell
0%
Similar Marketcap
This list is generated by looking at the six larger and six smaller companies by market cap in relation to this company.
Popular Stocks
This list is generated by looking at the top 100 stocks and ETFs most commonly held by Robinhood customers and showing a random subset
Newly Listed
This list is generated by showing companies that recently went public.